Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Nearly half of all drug shortages in 2022 were caused by quality issues or manufacturing delays, according to the Center for Drug Evaluation and Research (CDER). Evaluating the critical quality ...

A problem for biopharmaceutical companies comes as degraded proteins lead to ineffective and possibly dangerous medicines for their clients. Drug companies work on formulation development to protect ...

Formulation of biopharmaceuticals poses numerous challenges related to the chemical and physical properties of drugs, and the fact that nearly all such products are injected. Formulation development ...

The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs ...

The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering controlled release formulations that enhance patient compliance and therapeutic ...

Understand the challenges of liquid injectables and discover strategies to prevent stability issues and regulatory delays.

WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, expanded its patent ...

In this free webinar, see how formulation decisions directly impact Critical Quality Attributes. Attendees will learn how comprehensive analytical data informs robust control strategy development. The ...

Altruist Biologics, an Innovent Biologics subsidiary and contract development and manufacturing organisation, has launched Altru-CON- a high-concentration formulation technology platform created to ...